Tag: narrow therapeutic index
Switching from Brand to Generic: What Patients Should Expect
Discover what to expect when switching from brand-name to generic drugs. Learn about bioequivalence, cost savings, narrow therapeutic index risks, and practical tips for a safe transition.
Read More
Medical Society Guidelines on Generic Drugs: What Providers Need to Know
Explore how medical society guidelines shape generic drug use. From AAN's strict stance on anticonvulsants to NCCN's flexible oncology rules, learn what providers need to know about safety, bioequivalence, and patient care.
Read More
Multiple Manufacturers: NTI Drugs and Switching Between Generics
NTI drugs like warfarin, levothyroxine, and tacrolimus have a narrow safety margin-switching between generic manufacturers can affect blood levels and cause serious side effects. Learn why some patients need to avoid generic switches and how to protect your treatment.
Read More